Lv11
98 积分 2023-06-14 加入
Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present)
1小时前
待确认
Inhibitors of the PLK1 polo-box domain: drug design strategies and therapeutic opportunities in cancer
1小时前
已完结
Discovery of the erianin derivatives as EGFR/tubulin dual-target inhibitors that suppress the proliferation and invasion of non-small cell lung cancer through autophagy-dependent ferroptosis
4个月前
已完结
PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3
6个月前
已完结
Decoding the language of PLK1 docking motifs and activation mechanisms
8个月前
已关闭
Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination
8个月前
已关闭
Microtubule Targeting Agents: Basic Mechanisms of Multidrug Resistance (MDR)
10个月前
已完结
Polo kinase inhibits protein phosphatase 1 to promote the spindle assembly checkpoint and prevent aneuploidy
11个月前
已关闭
The spindle checkpoint, aneuploidy, and cancer
1年前
已完结
CDC20 assists its catalytic incorporation in the mitotic checkpoint complex
1年前
已完结
皖公网安备34019202002308
